This resulted in seven deaths and multiple injuries to various people, again, because of the inaccuracy in a specific set of ...

Here's a quick recap of the crypto landscape for Friday (December 19) as of 9:00 pm UTC. Get the latest insights on Bitcoin, Ether and altcoins, along with a round-up of key cryptocurrency market news ...

White House AI and crypto czar David Sacks said the CLARITY Act will reach the Senate next month for debate and amendment before a full vote. The long-awaited Digital Asset Market Clarity Act, or ...

DexCom, Inc. (NASDAQ:DXCM) is one of the stocks on Jim Cramer’s radar recently. A caller asked if they should buy, sell, or hold the stock during the lightning round. In response, Cramer said: “You ...

The Federal Reserve will make its final interest rate decision of 2025 on Wednesday, setting up a pivotal year for both the U.S. economy and the central bank as President Trump prepares to install a ...

Goals are standards that individuals use to evaluate how well they are doing now relative to where they want to end up. Goals basically guide our choices. Once you have a goal, the hard part is ...

President Donald Trump came into office promising to bring forth a golden age. To that end, he has sought to modernize American industry, expand America’s economy, and make America even more of a ...

“Diabetes does not happen in a vacuum,” said Dr. Roe. “We use CGM data alongside what is actually happening in a patient’s week so that adjustments feel practical and achievable, not overwhelming. The ...

The US FDA has cleared a new “basal insulin dose optimizer” function for the Dexcom G7 15-day continuous glucose monitor (CGM), which is set to launch separately on December 1, 2025. The “Smart Basal” ...

Weeks after launching its first open call for diabetes advocates, Dexcom is spotlighting the resulting group of 16 people in a new awareness campaign. The project kicked off Friday, World Diabetes Day ...

DexCom's growth rate has been accelerating for multiple quarters, and recently came in at around 22%. A rise in GLP-1 drugs has some investors concerned that DexCom's growth opportunities may be ...

Dexcom has been hit by a major safety issue for an Android version of its G6 continuous glucose monitoring system app, leading the FDA to issue its most serious recall notice. A “software defect in ...